tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
Holding VTGN?
Track your performance easily

VistaGen Therapeutics (VTGN) Income Statement

755 Followers

VistaGen Therapeutics Income Statement

Last quarter (Q4 2024), VistaGen Therapeutics's total revenue was $197.30K, an increase of Infinity% from the same quarter last year. In Q4, VistaGen Therapeutics's net income was $-9.52M. See VistaGen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 886.40K$ 1.06M$ -227.00K$ 1.11M$ 1.09M$ 0.00
Cost of Revenue
------
Gross Profit
$ 1.06M$ 1.06M$ -227.00K$ 1.11M$ 1.09M-
Operating Expense
$ 33.91M$ 34.09M$ 59.04M$ 48.89M$ 19.02M$ 19.97M
Operating Income
$ -33.02M$ -33.02M$ -59.27M$ -47.78M$ -19.02M$ -19.97M
Net Non Operating Interest Income Expense
$ 3.35M$ 3.35M$ 26.20K$ 19.90K$ 1.60K$ 30.00K
Other Income Expense
$ -312.00K$ -312.00K$ 77.40K-$ -1.09M$ -827.00K
Pretax Income
$ -29.36M$ -29.36M$ -59.24M$ -47.76M$ -40.93M$ -20.77M
Tax Provision
$ 4.00K$ 4.00K$ 5.90K$ 3.40K$ 2.60K$ 2.60K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.36M$ -29.36M$ -59.25M$ -48.71M$ -42.32M$ -22.04M
Basic EPS
$ -1.52$ -1.52$ -8.51$ -7.50$ -0.49$ -0.50
Diluted EPS
$ -1.52$ -1.52$ -8.51$ -7.50$ 0.00$ -0.50
Basic Average Shares
$ 77.42M$ 19.35M$ 6.96M$ 6.60M$ 86.13M$ 43.87M
Diluted Average Shares
$ 77.42M$ 19.35M$ 6.96M$ 6.60M$ 86.13M$ 43.87M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-----$ 354.00K
Total Expenses
$ 33.91M$ 34.09M$ 59.04M$ 48.89M$ 19.02M$ 19.97M
Net Income From Continuing And Discontinued Operation
$ -29.36M$ -29.36M$ -59.25M$ -47.76M$ -40.93M$ -20.77M
Normalized Income
$ -29.06M$ -29.06M$ -47.33M--$ -20.77M
Interest Expense
-----$ 15.00K
EBIT
$ -33.02M$ -33.02M$ -59.22M$ -47.78M$ -40.93M$ -20.76M
EBITDA
$ -25.81M$ -32.45M$ -58.69M$ -47.07M$ -41.05M$ -20.65M
Currency in USD

VistaGen Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis